Logo image of ADN.CA

ACADIAN TIMBER CORP (ADN.CA) Stock Fundamental Analysis

Canada - Toronto Stock Exchange - TSX:ADN - CA0042721005 - Common Stock

16.14 CAD
+0.24 (+1.51%)
Last: 1/9/2026, 7:00:00 PM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to ADN. ADN was compared to 12 industry peers in the Paper & Forest Products industry. ADN has an excellent profitability rating, but there are concerns on its financial health. ADN has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

ADN had positive earnings in the past year.
In the past year ADN had a positive cash flow from operations.
ADN had positive earnings in each of the past 5 years.
ADN had a positive operating cash flow in each of the past 5 years.
ADN.CA Yearly Net Income VS EBIT VS OCF VS FCFADN.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M

1.2 Ratios

The Return On Assets of ADN (2.36%) is better than 83.33% of its industry peers.
The Return On Equity of ADN (4.19%) is better than 83.33% of its industry peers.
ADN's Return On Invested Capital of 1.63% is fine compared to the rest of the industry. ADN outperforms 75.00% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for ADN is in line with the industry average of 4.04%.
Industry RankSector Rank
ROA 2.36%
ROE 4.19%
ROIC 1.63%
ROA(3y)5.08%
ROA(5y)4.63%
ROE(3y)9.11%
ROE(5y)8.26%
ROIC(3y)2.69%
ROIC(5y)2.83%
ADN.CA Yearly ROA, ROE, ROICADN.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

1.3 Margins

The Profit Margin of ADN (16.03%) is better than 100.00% of its industry peers.
ADN's Profit Margin has improved in the last couple of years.
ADN has a better Operating Margin (15.01%) than 100.00% of its industry peers.
ADN's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 30.11%, ADN belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
In the last couple of years the Gross Margin of ADN has remained more or less at the same level.
Industry RankSector Rank
OM 15.01%
PM (TTM) 16.03%
GM 30.11%
OM growth 3Y-3.67%
OM growth 5Y-1.71%
PM growth 3Y-1.44%
PM growth 5Y1.58%
GM growth 3Y0.77%
GM growth 5Y0.08%
ADN.CA Yearly Profit, Operating, Gross MarginsADN.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ADN is destroying value.
The number of shares outstanding for ADN has been increased compared to 1 year ago.
Compared to 5 years ago, ADN has more shares outstanding
The debt/assets ratio for ADN is higher compared to a year ago.
ADN.CA Yearly Shares OutstandingADN.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
ADN.CA Yearly Total Debt VS Total AssetsADN.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

Based on the Altman-Z score of 1.14, we must say that ADN is in the distress zone and has some risk of bankruptcy.
ADN has a Altman-Z score (1.14) which is in line with its industry peers.
ADN has a debt to FCF ratio of 32.89. This is a negative value and a sign of low solvency as ADN would need 32.89 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 32.89, ADN is in line with its industry, outperforming 58.33% of the companies in the same industry.
A Debt/Equity ratio of 0.33 indicates that ADN is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.33, ADN is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.33
Debt/FCF 32.89
Altman-Z 1.14
ROIC/WACC0.26
WACC6.27%
ADN.CA Yearly LT Debt VS Equity VS FCFADN.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

ADN has a Current Ratio of 0.96. This is a bad value and indicates that ADN is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of ADN (0.96) is worse than 83.33% of its industry peers.
A Quick Ratio of 0.88 indicates that ADN may have some problems paying its short term obligations.
ADN has a Quick ratio of 0.88. This is comparable to the rest of the industry: ADN outperforms 58.33% of its industry peers.
Industry RankSector Rank
Current Ratio 0.96
Quick Ratio 0.88
ADN.CA Yearly Current Assets VS Current LiabilitesADN.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

1

3. Growth

3.1 Past

The earnings per share for ADN have decreased strongly by -48.15% in the last year.
The Earnings Per Share has been decreasing by -9.80% on average over the past years.
ADN shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -28.86%.
ADN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.05% yearly.
EPS 1Y (TTM)-48.15%
EPS 3Y4.63%
EPS 5Y-9.8%
EPS Q2Q%23.08%
Revenue 1Y (TTM)-28.86%
Revenue growth 3Y6.68%
Revenue growth 5Y3.05%
Sales Q2Q%-11.33%

3.2 Future

The Earnings Per Share is expected to decrease by -4.83% on average over the next years.
Based on estimates for the next years, ADN will show a decrease in Revenue. The Revenue will decrease by -3.68% on average per year.
EPS Next Y-52.71%
EPS Next 2Y-22.98%
EPS Next 3Y-10.65%
EPS Next 5Y-4.83%
Revenue Next Year-28.61%
Revenue Next 2Y-2.74%
Revenue Next 3Y-3.68%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ADN.CA Yearly Revenue VS EstimatesADN.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M 80M 100M
ADN.CA Yearly EPS VS EstimatesADN.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0.5 1 1.5 2

4

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 19.21, the valuation of ADN can be described as rather expensive.
Based on the Price/Earnings ratio, ADN is valued cheaply inside the industry as 83.33% of the companies are valued more expensively.
When comparing the Price/Earnings ratio of ADN to the average of the S&P500 Index (27.19), we can say ADN is valued slightly cheaper.
Based on the Price/Forward Earnings ratio of 21.59, the valuation of ADN can be described as rather expensive.
Based on the Price/Forward Earnings ratio, ADN is valued a bit cheaper than 66.67% of the companies in the same industry.
ADN's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 23.88.
Industry RankSector Rank
PE 19.21
Fwd PE 21.59
ADN.CA Price Earnings VS Forward Price EarningsADN.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

ADN's Enterprise Value to EBITDA is on the same level as the industry average.
The rest of the industry has a similar Price/Free Cash Flow ratio as ADN.
Industry RankSector Rank
P/FCF 87.67
EV/EBITDA 27.82
ADN.CA Per share dataADN.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

ADN has an outstanding profitability rating, which may justify a higher PE ratio.
A cheap valuation may be justified as ADN's earnings are expected to decrease with -10.65% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-22.98%
EPS Next 3Y-10.65%

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 7.30%, ADN is a good candidate for dividend investing.
ADN's Dividend Yield is rather good when compared to the industry average which is at 2.56. ADN pays more dividend than 91.67% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 1.94, ADN pays a better dividend.
Industry RankSector Rank
Dividend Yield 7.3%

5.2 History

The dividend of ADN decreases each year by -10.56%.
ADN has paid a dividend for at least 10 years, which is a reliable track record.
The dividend of ADN decreased recently.
Dividend Growth(5Y)-10.56%
Div Incr Years1
Div Non Decr Years1
ADN.CA Yearly Dividends per shareADN.CA Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1

5.3 Sustainability

73.33% of the earnings are spent on dividend by ADN. This is not a sustainable payout ratio.
ADN's earnings and Dividend Rate are declining. This means the current dividend is most likely not sustainable.
DP73.33%
EPS Next 2Y-22.98%
EPS Next 3Y-10.65%
ADN.CA Yearly Income VS Free CF VS DividendADN.CA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M
ADN.CA Dividend Payout.ADN.CA Dividend Payout, showing the Payout Ratio.ADN.CA Dividend Payout.PayoutRetained Earnings

ACADIAN TIMBER CORP

TSX:ADN (1/9/2026, 7:00:00 PM)

16.14

+0.24 (+1.51%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryPaper & Forest Products
Earnings (Last)10-29 2025-10-29/amc
Earnings (Next)02-10 2026-02-10
Inst Owners8.29%
Inst Owner ChangeN/A
Ins Owners0.7%
Ins Owner ChangeN/A
Market Cap295.20M
Revenue(TTM)85.21M
Net Income(TTM)14.13M
Analysts76.67
Price Target18.11 (12.21%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 7.3%
Yearly Dividend0.66
Dividend Growth(5Y)-10.56%
DP73.33%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-5.32%
Min EPS beat(2)-40.59%
Max EPS beat(2)29.95%
EPS beat(4)2
Avg EPS beat(4)36.33%
Min EPS beat(4)-40.59%
Max EPS beat(4)164.03%
EPS beat(8)5
Avg EPS beat(8)101.8%
EPS beat(12)9
Avg EPS beat(12)176.18%
EPS beat(16)11
Avg EPS beat(16)130.41%
Revenue beat(2)1
Avg Revenue beat(2)-9.79%
Min Revenue beat(2)-31.34%
Max Revenue beat(2)11.76%
Revenue beat(4)1
Avg Revenue beat(4)-7.73%
Min Revenue beat(4)-31.34%
Max Revenue beat(4)11.76%
Revenue beat(8)2
Avg Revenue beat(8)-0.37%
Revenue beat(12)4
Avg Revenue beat(12)-1.15%
Revenue beat(16)6
Avg Revenue beat(16)-0.65%
PT rev (1m)0%
PT rev (3m)-8.97%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)-37.57%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-14.33%
Valuation
Industry RankSector Rank
PE 19.21
Fwd PE 21.59
P/S 3.35
P/FCF 87.67
P/OCF 42.23
P/B 0.88
P/tB 0.89
EV/EBITDA 27.82
EPS(TTM)0.84
EY5.2%
EPS(NY)0.75
Fwd EY4.63%
FCF(TTM)0.18
FCFY1.14%
OCF(TTM)0.38
OCFY2.37%
SpS4.82
BVpS18.41
TBVpS18.07
PEG (NY)N/A
PEG (5Y)N/A
Graham Number18.65
Profitability
Industry RankSector Rank
ROA 2.36%
ROE 4.19%
ROCE 2.27%
ROIC 1.63%
ROICexc 1.64%
ROICexgc 1.65%
OM 15.01%
PM (TTM) 16.03%
GM 30.11%
FCFM 3.82%
ROA(3y)5.08%
ROA(5y)4.63%
ROE(3y)9.11%
ROE(5y)8.26%
ROIC(3y)2.69%
ROIC(5y)2.83%
ROICexc(3y)2.73%
ROICexc(5y)2.88%
ROICexgc(3y)2.76%
ROICexgc(5y)2.92%
ROCE(3y)3.75%
ROCE(5y)3.95%
ROICexgc growth 3Y0.45%
ROICexgc growth 5Y-5.14%
ROICexc growth 3Y0.47%
ROICexc growth 5Y-5.06%
OM growth 3Y-3.67%
OM growth 5Y-1.71%
PM growth 3Y-1.44%
PM growth 5Y1.58%
GM growth 3Y0.77%
GM growth 5Y0.08%
F-Score3
Asset Turnover0.15
Health
Industry RankSector Rank
Debt/Equity 0.33
Debt/FCF 32.89
Debt/EBITDA 7.67
Cap/Depr 328.17%
Cap/Sales 4.11%
Interest Coverage 3.75
Cash Conversion 48.76%
Profit Quality 23.84%
Current Ratio 0.96
Quick Ratio 0.88
Altman-Z 1.14
F-Score3
WACC6.27%
ROIC/WACC0.26
Cap/Depr(3y)780.67%
Cap/Depr(5y)518.79%
Cap/Sales(3y)3.37%
Cap/Sales(5y)2.17%
Profit Quality(3y)61.15%
Profit Quality(5y)72.04%
High Growth Momentum
Growth
EPS 1Y (TTM)-48.15%
EPS 3Y4.63%
EPS 5Y-9.8%
EPS Q2Q%23.08%
EPS Next Y-52.71%
EPS Next 2Y-22.98%
EPS Next 3Y-10.65%
EPS Next 5Y-4.83%
Revenue 1Y (TTM)-28.86%
Revenue growth 3Y6.68%
Revenue growth 5Y3.05%
Sales Q2Q%-11.33%
Revenue Next Year-28.61%
Revenue Next 2Y-2.74%
Revenue Next 3Y-3.68%
Revenue Next 5YN/A
EBIT growth 1Y-48.28%
EBIT growth 3Y2.77%
EBIT growth 5Y1.28%
EBIT Next Year-37.55%
EBIT Next 3Y3.4%
EBIT Next 5YN/A
FCF growth 1Y-70.57%
FCF growth 3Y13.98%
FCF growth 5YN/A
OCF growth 1Y-41.26%
OCF growth 3Y28.01%
OCF growth 5YN/A

ACADIAN TIMBER CORP / ADN.CA FAQ

What is the ChartMill fundamental rating of ACADIAN TIMBER CORP (ADN.CA) stock?

ChartMill assigns a fundamental rating of 4 / 10 to ADN.CA.


Can you provide the valuation status for ACADIAN TIMBER CORP?

ChartMill assigns a valuation rating of 4 / 10 to ACADIAN TIMBER CORP (ADN.CA). This can be considered as Fairly Valued.


How profitable is ACADIAN TIMBER CORP (ADN.CA) stock?

ACADIAN TIMBER CORP (ADN.CA) has a profitability rating of 8 / 10.


What are the PE and PB ratios of ACADIAN TIMBER CORP (ADN.CA) stock?

The Price/Earnings (PE) ratio for ACADIAN TIMBER CORP (ADN.CA) is 19.21 and the Price/Book (PB) ratio is 0.88.


What is the financial health of ACADIAN TIMBER CORP (ADN.CA) stock?

The financial health rating of ACADIAN TIMBER CORP (ADN.CA) is 2 / 10.